Archived Content
This page is archived and provided for historical reference. The content is no longer being updated, and some of the information may have changed over time and could be outdated or inaccurate.
November 22, 2022
Director's Voice Blog
NIH Behavioral and Social Sciences Research Festival: Celebrating Advances in Science. On December 8 and 9 (1:00-4:30 p.m. EST), OBSSR and the NIH Behavioral and Social Sciences Research Coordinating Committee will host the seventh annual NIH Behavioral and Social Sciences Research Festival. This annual event provides a venue for the NIH Institutes and Centers to highlight exciting research results, emerging research areas, and innovations in the behavioral and social sciences. We hope you will save the date on your calendar and register here for this virtual event.
We have an excellent line-up of speakers this year. On December 8, we are pleased to launch the festival with a “fireside chat” featuring Alix Spiegel, the well-known public radio producer and science journalist. She will share her experience and insights on the state of science of communication and how to communicate scientific findings more effectively.
Behavioral and Social Sciences Research Spotlights
Telehealth lifestyle intervention reduces blood pressure, with dietitian support leading to greater improvements in secondary cardiometabolic outcomes
In the U.S., hypertension (high blood pressure) is a significant cause of morbidity and mortality and affects over 120 million adults aged 20 years of age and older. Unhealthy dietary patterns, high sodium intake, low physical activity, and obesity all contribute to the development of hypertension and cardiovascular disease. Interventions that help individuals lower their blood pressure (BP) is challenging in clinical practice, often due to a lack of time and resources. Telehealth interventions that use mobile applications and online programs could be helpful by providing patients with insights about their own data and have the potential to reach patients living in rural areas.
Recently published research supported by NIDDK and others, examined the impact of two different telehealth strategies (minimal remote nonclinical staff support versus remote dietitian support with motivational interviewing) that leveraged online programs and mobile applications to promote healthy behavior change on 12-week changes in 24-hour systolic BP and other measures of healthy lifestyle.
Family caregivers face unique challenges caring for discharged COVID-19 ICU patients
Family caregiving can be characterized as providing unpaid care and assistance for a family member or friend’s health, behavioral, and social needs. Around 21% of COVID-19 hospitalized patients required an intensive care unit (ICU) stay for respiratory and cardiovascular complications at the height of the pandemic and necessitated caregiver assistance from family upon discharge. While there was an increase in the amount of family caregivers, there is scarce information about the post-hospitalization family caregiving experience and strategies to best support those transitioning into a caregiving role. Recently published research supported by the NIA, NINR, VA, and others may be one of the first studies to use dyadic (discharged COVID-19 ICU patients and their family caregivers) qualitative data to investigate the adaptive needs of families following an infective condition and ICU discharge. Study results could lead to improved family health outcomes and support needs as well as points of interventions for clinicians.
Read More
Changing state policy contexts are associated with increasing mortality rates among working-age adults in the U.S. ages 25-64 over the past two decades
Working-age mortality rates among adults in the United States (U.S.) ages 25-64 has increased over the past several decades, resulting in overall stagnation of U.S. life expectancy. Prior research has shown that several factors contributed to rising mortality rates, including noncommunicable diseases (particularly cardiovascular disease), unintentional injuries (e.g., alcohol-induced causes or drug poisonings), and intentional injuries (e.g., suicide). More recent work has shown that increases in U.S. mortality rates are also associated with macro-level influences, including social, political, and cultural factors. Political and policy shifts may have marked impacts on health and well-being, particularly at the state level where policy may determine such factors as education, economic stability, encouragement/discouragement of risky behaviors (e.g., tobacco taxes), access to health care, or employment protections and benefits. To date, the role of U.S. state policy contexts on the changing mortality rates of working-age adults has not yet been addressed. Recently published research supported by NIA has built on past work to investigate how state policy contexts in the past two decades are associated with working-age mortality rates overall among adults 25-64 years of age, and attributable to cardiovascular disease, alcohol-induced causes, suicide, and drug poisoning.
Go There Now
News and Events
Register Now: Fireside Chat with Alix Spiegel at the NIH Behavioral and Social Sciences Research Festival
Join OBSSR virtually on Thursday, December 8 and Friday, December 9, 2022, from 1:00 p.m. to 4:30 p.m. ET each day, for the annual NIH Behavioral and Social Sciences Research (BSSR) Festival.
On Thursday, December 8, NIH OBSSR Acting Director Christine Hunter, Ph.D., ABPP, will deliver opening remarks, and will moderate a “Fireside Chat on Health Communications” with Alix Spiegel. Alix is a public radio producer and science journalist who was one of the founding producers of “This American Life” and a human behavior reporter for National Public Radio’s science desk. Over the course of her career in public radio, she has won many awards including a George Foster Peabody Award, a Livingston Award, an Alfred I. duPont-Columbia University Award, a Scripps Howard National Journalism Award, and a Robert F. Kennedy Journalism Award. After a series of scientific presentations spread across two sessions, Dr. Hunter will conclude the first day of the festival with a “State of Behavioral and Social Sciences Research (BSSR) at NIH” presentation.
Register to attend and view the full festival agenda and speaker biographies: https://www.scgcorp.com/OBSSRFestival2022/Registration.
Individuals who need reasonable accommodations to participate in this event should contact Danielle Johnikin at [email protected] and/or (301) 670-4990 by November 28, 2022. If you have questions about registering or accessing this event, please contact Danielle Johnikin at [email protected].
Technical Assistance Webinar for BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level
NIDA and the NIH BRAIN Initiative announces pre-application and technical assistance webinars in November to provide information regarding a new funding opportunity announcement (FOA) [NOT-DA-22-083] BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed). This FOA solicits applications to support the planning of projects that advance simultaneous capture of behavioral and physiological data at the organismal level and environmental data to ultimately develop new computational models of behavior as a complex dynamic system.
Webinar Information:
Monday, November 28, 2022 at 1:00 p.m. ET. The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant.
Those interested should see NOT-DA-22-083 for more information. Please direct all inquiries to [email protected].
Apply Today: Mixed Methods Research Training Program for the Health Sciences
Applications are now open for the 2023 Mixed Methods Research Training Program for the Health Sciences. The program, funded by OBSSR, fulfills a national need for training in mixed methods and is a natural next step following the publication of OBSSR's "Best Practices for Mixed Methods Research in the Health Sciences." Selected scholars have access to webinars, resources, come to an in-person retreat to discuss their research project, and are matched with mixed methods expert consultants. The program has reported results in three peer-reviewed publications.
The deadline for submission is Friday January 13, 2023 at 5pm ET. The MMRTP Retreat will be held in summer 2023.
Apply Now: Summer Institute on Randomized Behavioral Clinical Trials
The 23rd annual Summer Institute on Randomized Behavioral Clinical Trials will be held from July 12 – 22, 2023, at the Bolger Hotel and Conference Center in Potomac, Maryland. The Institute is sponsored by OBSSR and the National Heart, Lung, and Blood Institute (NHLBI).
Learn more about the training objectives, agenda, eligibility requirements and more on the OBSSR website.
Please address questions about eligibility to apply for the Summer Institute or about the program to Kenneth Freedland, PhD, Program Director, at [email protected].
Applications are due by February 21, 2023.
Call for Papers: Public Health Reports Supplement Issue on COVID-19, Stay-at-Home Orders, and Interpersonal Violence: Findings and Implications for Emergency Response Efforts
Public Health Reports, the official journal of the Office of the US Surgeon General and the US Public Health Service, recently announced a new call for papers for the Public Health Reports Supplement Issue on “COVID-19, Stay-at-Home Orders, and Interpersonal Violence: Findings and Implications for Emergency Response Efforts.” The supplement, sponsored by OTIP, aims to build the evidence base on pandemic preparedness, emergency response efforts, and strategies that prevent and respond to interpersonal violence such as child maltreatment, domestic violence, and human trafficking.
The editors encourage submissions that draw on an equity lens and address populations which are under-researched (e.g., at-risk populations and those experiencing exploitation who have received limited attention in scientific studies such as people who have experienced labor trafficking; American Indian, Alaskan Native, Native Hawaiian and Pacific Islanders; unaccompanied migrant minors; men and boys; and transgender populations). The submission deadline for full manuscripts is March 23, 2023. More information on the supplement is available via the OTIP webpage.
Webinar Recording Available: Webs of Wellness: Connections Between Mind, Body, and Community for Making Change
On September 27, 2022, OBSSR hosted a director's webinar featuring Dr. Emily Falk on “Webs of Wellness: Connections Between Mind, Body, and Community for Making Change.” Dr. Emily Falk studies behavior change, persuasion, and how ideas and behaviors spread. She is a Professor of Communication, Psychology, Marketing, and Operations, Information and Decisions, at the University of Pennsylvania; Associate Dean for Research at the Annenberg School for Communication; Director of Penn's Communication Neuroscience Lab; and a Distinguished Fellow of the Annenberg Public Policy Center.
Access the recording on the OBSSR website.
Recently Published Funding Announcements
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
Notice Number
NOT-OD-23-002
Key Dates
First Available Due Date: February 17, 2023
Expiration Date: February 18, 2023
Purpose
The participating Institutes and Centers (ICs) are inviting applications to support administrative supplements to existing NIH awards to support scientists who have demonstrated compelling commitments and contributions to mentorship and enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. Funds will support ongoing and future efforts.
The biomedical research enterprise includes a range of research, including basic science, behavioral and social science, and clinical research and will be described hereafter as biomedical research. Excellent mentorship and superior training are critical to developing exceptional future scientists and building a diverse scientific workforce in the U.S. However, these efforts may not always be appropriately recognized or well compensated. As such, the intent of this NOSI is to reach those individuals with limited NIH support.
BSSR Accomplishments
The NIH has been an instrumental leader in shaping and supporting behavioral and social sciences research (BSSR) to improve the nation’s health. Integrated with advances in other scientific disciplines, BSSR has made substantial contributions to the prevention or treatment of numerous physical health and mental health conditions.
In collaboration with subject matter experts from Institutes, Centers, and Offices across NIH, OBSSR has summarized some of the important scientific advances that demonstrate the valuable contribution of BSSR across various health conditions and behaviors. These summaries are provided as fact sheets (PowerPoint slides forthcoming) that highlight a significant public health problem and the corresponding BSSR-informed approaches used to address the problem. Various audiences such as academic researchers, public health organizations, and other health federal agencies, may find these materials useful to demonstrate to their stakeholders the importance of BSSR to the health of the United States population.
These new BSSR accomplishment resources are available on the OBSSR website:
Improving Sleep
Managing Chronic Pain
Preventing and Treating Diabetes
Preventing Intimate Partner Violence
Reducing Teen Pregnancy
Reducing Tobacco Use
Treating Depression
Treating Obsessive-Compulsive Disorder
Treating Phobias
Treating Post-Traumatic Stress Disorder
Additional BSSR accomplishments will be added to the website in 2023.
BSSR Clinical Trials Resources
The Clinical Trials Protocol Template for the Behavioral and Social Sciences is a resource for communicating the science, methods, and operations of a clinical trial. This template is a suggested format for clinical trials that are testing a behavioral or social intervention or experimental manipulation. Use of the protocol template is encouraged but not required.
The Behavioral and Social Clinical Trials Template was derived from the successful NIH-FDA Phase 2/3 IND-IDE Clinical Trial Template but was adapted to include terminology and approaches used by behavioral and social scientists. While the template is a suggested format for clinical trials that are testing a behavioral or social intervention or manipulation for which a stand-alone clinical protocol is required, the template can also be a useful tool for those trials funded by NIH Institutes or Centers that do not require stand-alone clinical protocols. Using the template to anticipate decision points and potential challenges before a study launches can help avoid subsequent delays and problems.
The DECISION SUPPORT TOOL: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III is the result of a working group led by OBSSR, with participants from other NIH Institutes, Centers, and Offices. It is a designed to be a resource to help investigators, program officers, and reviewers determine if a behavioral or social science study is better characterized as a Phase II or a Phase III clinical trial. Distinguishing earlier phases of clinical trials (Phase 0 or I) is not usually difficult but distinguishing between a Phase II and III study can be more challenging, particularly for non-drug trials. Being thoughtful about this distinction is important for a variety of reasons, not least of which is that a Phase III designation for an NIH funded clinical trial generally requires following additional policies and practices beyond those that already apply to Phase II clinical trials, such as the requirement for valid analysis and for a Data and Safety Monitoring Board (DSMB). Data and safety monitoring are required for all clinical trials but for a Phase III trial, the constitution of a board is required.
NIH’s definition of a Phase III Clinical Trial is quite broad, including drug studies, device studies, behavioral interventions, epidemiological studies, community trials, and more. Phase III trials are usually large, prospective trials that compare two or more interventions against other standard or experimental interventions. In this next episode of our NIH All About Grants podcast (MP3 / Transcript) we explain what a Phase III trial is, how it compares to other types of clinical trials, considerations for your application and its review, how these studies influence standards of care, helpful tools and other resources, and much more. The guests include Ms. Dawn Corbett, NIH’s Inclusion Policy Officer, and Dr. Christine Hunter, OBSSR Acting Director.
Social and Behavioral Good Clinical Practice eCourse
In September 2016, the NIH issued a Policy on Good Clinical Practice (GCP) Training for NIH Awardees Involved in NIH-funded Clinical Trials. GCP is an international ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. The principles of GCP help assure the safety, integrity, and quality of clinical trials. Investigators and clinical trial staff who are competent in GCP principles will be better able to assure that the rights, safety, and well-being of human subjects are protected; that clinical trials are conducted in accordance with approved plans and with rigor and integrity; and that data derived from clinical trials are reliable.
Extramural Researchers can go here to take the course.
NIH Employees can go here to take the course. (NIH login required)
Educational Facilities can Download the Good Clinical Practices for Social and Behavioral Sciences Course for your educational facility's Learning Management System (LMS).


